Mark Wegter is a Partner in theEQT Life Sciences team. Mark was Managing Partner at LSP from 1999 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Mark was a Senior Analyst at ING Corporate and Investment Banking. Mark brings close to 25 years of hands-on specialist finance and investment experience to the EQT Life Sciences team. Over the past two decades, Mark has been a non-Executive Board Member in a number of innovative life sciences companies, both privately held and publicly listed, across Europe.
Mark holds a Master’s degree in Business Economics from the Erasmus University of Rotterdam, The Netherlands.